Cargando…
Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides
A series of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzenesulfonamide derivatives (1–32) was synthesized and evaluated for its in vitro antimicrobial, antiviral and cytotoxic activities. Antimicrobial results indicated that compounds (11) and (18) were found to be the most e...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Production and hosting by Elsevier B.V.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185680/ http://dx.doi.org/10.1016/j.arabjc.2012.12.005 |
_version_ | 1783526807830528000 |
---|---|
author | Kumar, Mahesh Ramasamy, Kalavathy Mani, Vasudevan Mishra, Rakesh Kumar Majeed, Abu Bakar Abdul Clercq, Erik De Narasimhan, Balasubramanian |
author_facet | Kumar, Mahesh Ramasamy, Kalavathy Mani, Vasudevan Mishra, Rakesh Kumar Majeed, Abu Bakar Abdul Clercq, Erik De Narasimhan, Balasubramanian |
author_sort | Kumar, Mahesh |
collection | PubMed |
description | A series of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzenesulfonamide derivatives (1–32) was synthesized and evaluated for its in vitro antimicrobial, antiviral and cytotoxic activities. Antimicrobial results indicated that compounds (11) and (18) were found to be the most effective ones. In general, the synthesized compounds were bacteriostatic and fungistatic in their action. The cytotoxic screening results indicated that the compounds were less active than the standard drug 5-fluorouracil (5-FU). None of the compounds inhibited viral replication at subtoxic concentrations. In general, the presence of a pyrimidine ring with electron releasing groups and an ortho- and para-substituted benzoyl moiety favored antimicrobial activities. The results of QSAR studies demonstrated the importance of topological parameters, valence zero order molecular connectivity index ((0)χ(v)) and valence first order molecular connectivity index ((1)χ(v)) in describing the antimicrobial activity of synthesized compounds. |
format | Online Article Text |
id | pubmed-7185680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Production and hosting by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71856802020-04-28 Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides Kumar, Mahesh Ramasamy, Kalavathy Mani, Vasudevan Mishra, Rakesh Kumar Majeed, Abu Bakar Abdul Clercq, Erik De Narasimhan, Balasubramanian Arab J Chem Original Article A series of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzenesulfonamide derivatives (1–32) was synthesized and evaluated for its in vitro antimicrobial, antiviral and cytotoxic activities. Antimicrobial results indicated that compounds (11) and (18) were found to be the most effective ones. In general, the synthesized compounds were bacteriostatic and fungistatic in their action. The cytotoxic screening results indicated that the compounds were less active than the standard drug 5-fluorouracil (5-FU). None of the compounds inhibited viral replication at subtoxic concentrations. In general, the presence of a pyrimidine ring with electron releasing groups and an ortho- and para-substituted benzoyl moiety favored antimicrobial activities. The results of QSAR studies demonstrated the importance of topological parameters, valence zero order molecular connectivity index ((0)χ(v)) and valence first order molecular connectivity index ((1)χ(v)) in describing the antimicrobial activity of synthesized compounds. Production and hosting by Elsevier B.V. 2014-09 2012-12-13 /pmc/articles/PMC7185680/ http://dx.doi.org/10.1016/j.arabjc.2012.12.005 Text en Copyright © 2012 Production and hosting by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Kumar, Mahesh Ramasamy, Kalavathy Mani, Vasudevan Mishra, Rakesh Kumar Majeed, Abu Bakar Abdul Clercq, Erik De Narasimhan, Balasubramanian Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides |
title | Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides |
title_full | Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides |
title_fullStr | Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides |
title_full_unstemmed | Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides |
title_short | Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides |
title_sort | synthesis, antimicrobial, anticancer, antiviral evaluation and qsar studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-n-substituted benzene sulfonamides |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185680/ http://dx.doi.org/10.1016/j.arabjc.2012.12.005 |
work_keys_str_mv | AT kumarmahesh synthesisantimicrobialanticancerantiviralevaluationandqsarstudiesof41aryl2oxo12dihydroindol3ylideneaminonsubstitutedbenzenesulfonamides AT ramasamykalavathy synthesisantimicrobialanticancerantiviralevaluationandqsarstudiesof41aryl2oxo12dihydroindol3ylideneaminonsubstitutedbenzenesulfonamides AT manivasudevan synthesisantimicrobialanticancerantiviralevaluationandqsarstudiesof41aryl2oxo12dihydroindol3ylideneaminonsubstitutedbenzenesulfonamides AT mishrarakeshkumar synthesisantimicrobialanticancerantiviralevaluationandqsarstudiesof41aryl2oxo12dihydroindol3ylideneaminonsubstitutedbenzenesulfonamides AT majeedabubakarabdul synthesisantimicrobialanticancerantiviralevaluationandqsarstudiesof41aryl2oxo12dihydroindol3ylideneaminonsubstitutedbenzenesulfonamides AT clercqerikde synthesisantimicrobialanticancerantiviralevaluationandqsarstudiesof41aryl2oxo12dihydroindol3ylideneaminonsubstitutedbenzenesulfonamides AT narasimhanbalasubramanian synthesisantimicrobialanticancerantiviralevaluationandqsarstudiesof41aryl2oxo12dihydroindol3ylideneaminonsubstitutedbenzenesulfonamides |